not yet imo breaking system
the exclusive joint development and license agreement across 10yrs in 'australia' for the insomnia market is 10x 235/255 million annually at 2024 numbers
I believe we'll find that US 3 million is a down payment for that exclusive access on the US 16 million development milestone payments prior to commercialisation in Aus.
Dr Paul has negotiated a solid agreement it seems - Sandoz Group AG understand the 'opportunity' this drug if successful presents
gotta let the details soak out across markets
just my view of course
Ann: Avecho & Sandoz Sign Deal to Develop CBD for Insomnia in AUS, page-109
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $14.28M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $897 | 199.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 54 | 44546678 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 9339191 | 6 |
View Market Depth
| Last trade - 10.05am 08/08/2025 (20 minute delay) ? |
| AVE (ASX) Chart |